Skip to main content
Clinical Trials/IRCT20120915010841N21
IRCT20120915010841N21
Recruiting
Phase 2

Comparative Evaluation of intravenous Propofol and Midazolam on sedation and nausea & vomiting during spinal anesthesia in cesarean section

Hamedan University of Medical Sciences0 sites102 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
sedation and nausea & vomiting during spinal anesthesia in cesarean section.
Sponsor
Hamedan University of Medical Sciences
Enrollment
102
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • 18\-45 aged pregnant women for C/S
  • ASA CLASS 1, 2
  • Satisfaction to participate in the project
  • Pregnant women who underwent cesarean section under spinal anesthesia

Exclusion Criteria

  • sensitivity to medications used
  • Patients who have failed spinal anesthesia and undergo general anesthesia
  • Lung disease, heart disease, asthma, fever, hypertension, preeclampsia and eclampsia, cardiac arrhythmia
  • Emergency Cesarean
  • Eclampsia and Preeclampsia
  • Multiple pregnancy
  • Spinal anesthesia contraindications (high ICP, hypovolemia, anemia, coagulation disorders, etc.)
  • History of allergy to eggs, soy, midazolam and propofol
  • Use of antiemetic drugs

Outcomes

Primary Outcomes

Not specified

Similar Trials